NCT05924256View on ClinicalTrials.gov

A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing

PHASE2RecruitingINTERVENTIONAL

Enrollment

88

Participants

Timeline

Start Date

July 26, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions

Advanced Salivary Gland Carcinoma

Interventions

DRUG

SHR-A1811

SHR-A1811

DRUG

SHR 3680 + leuprolide

SHR 3680 + leuprolide

DRUG

SHR-A1921

SHR-A1921

DRUG

SHR-A1811

SHR-A1811

Trial Locations (1)

Unknown

RECRUITING

Dongmei Ji, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER